Table 2. Risk factors associated with dysglycaemia in the 2005 and 2015 cohorts.
2005 | 2015 | ||||
---|---|---|---|---|---|
r | p | r | p | ||
GENDER | 0.02 | 0.721a | 0.03 | 0.311a | |
AGE | Median Years | 0.19 | <0.001b | 0.60 | <0.001b |
ETHNICITY | White | 0.07 | 0.325a | 0.08 | 0.531a |
Black African | 0.06 | 0.506a | 0.08 | 0.358a | |
Black Caribbean | 0.10 | 0.108a | 0.06 | 0.253a | |
BMId | Median (kg/m2) | 0.04 | 0.423b | 0.17 | 0.001b |
WAISTd | Median | 0.24 | <0.001b | 0.27 | <0.001b |
IDF Definition | 0.30 | <0.001a | 0.26 | <0.001a | |
HYPERTENSION | Current | 0.18 | 0.001a | 0.39 | <0.001a |
LIPIDS | Total Cholesterol | 0.09 | 0.118b | 0.05 | 0.438b |
HDL | 0.05 | 0.335b | 0.13 | 0.016b | |
LDLc | 0.10 | 0.072b | |||
Triglyceridesd | 0.11 | 0.038b | 0.30 | <0.001b | |
HDL:TG Ratio | 0.08 | 0.130b | 0.27 | <0.001b | |
METABOLIC SYNDROME | Current | 0.58 | <0.001a | 0.63 | <0.001a |
SMOKING | Current | 0.01 | 0.716a | 0.12 | 0.905a |
CVD (excluding stroke) | Current or historic | 0.10 | 0.170a | 0.11 | 0.050a |
STATIN USE | Current | 0.14 | 0.043a | 0.40 | <0.001a |
STROKE | Current or historic | 0.10 | 0.109a | ||
% 10-YEAR CVD RISK | Framingham, mean | 0.07 | 0.210b | 0.39 | <0.001b |
HIV Duration | Mean Years | 0.11 | 0.046b | 0.18 | <0.001b |
ARV | Treated | 0.13 | 0.018a | 0.17 | 0.009a |
ARVs ASSOCIATED WITH DYSGLYCAEMIA | 0.01 | 0.878a | 0.16 | 0.002a | |
PERCENTAGE WEIGHT GAIN IN YEAR FOLLOWING INITITATION OF ARVsc | 0.34 | <0.001b | |||
LIPODYSTROPHY | Current or historic | 0.20 | 0.061a | 0.15 | 0.007a |
HEPATITIS B | Current | 0.01 | 0.873a | 0.04 | 0.421a |
HEPATITIS C | Current | 0.09 | 0.170a | 0.01 | 0.930a |
CD4 NADIRc | Mean | 0.01 | 0.082b | ||
VITAMIN Dc | Mean | 0.11 | 0.134b | ||
HEPATIC STEATOSISc | Current | 0.45 | <0.001a | ||
CHRONIC KIDNEY DISEASEc | Current | 0.10 | 0.073a | ||
CORTICOSTEROID THERAPYc | Current or historic | 0.14 | 0.014a | ||
1st or 2nd DEGREE RELATIVE WITH T2Dc | 0.10 | 0.076a | |||
PHYSICAL ACTIVITYc | Hours per week | 0.20 | <0.001b | ||
FRUITS & VEGETABLESc | Portions per day | 0.06 | 0.260b |
Participants grouped as normal or dysglycaemia (impaired fasting glucose and type 2 diabetes)
r = correlation coefficient; p = significance.
a Significance by Pearson Chi-squared test with Phi correlation;
b Significance by Pearson Correlation;
c Data not collected in 2005;
d Non-normal distribution log-transformed